Addressing Disparities in European Cancer Outcomes: a Qualitative Study Protocol of the BEACON Project

Overview

Journal Front Psychol

Date 2024 Mar 12

PMID 38469221

Authors

Giulia Ferraris

Veronica Coppini

Dario Monzani

Roberto Grasso

Iva Kirac

Denis Horgan

Ricardo Pietrobon

Victor Galvao

Gabriella Pravettoni

Affiliations

Soon will be listed here.

Abstract

Introduction: Health disparities represent a crucial factor in cancer survival rates, awareness, quality of life, and mental health of people receiving a cancer diagnosis and their families. Income, education, geographic location, and ethnicity are some of the most important underlying reasons for health disparities in cancer across Europe. Costs of healthcare, access to information, psycho-oncological support options, integration of cancer research and innovative care, and multidisciplinary cancer teams are the main target areas when it comes to addressing disparities in the cancer context. As part of the Beacon Project (BEACON), we developed a protocol for a qualitative study to explore and identify any relevant reasons for cancer inequalities and disparities in Europe.

Methods: Our four stakeholders namely, cancer patients, healthcare providers, researchers, and policymakers will be recruited online, facilitated by collaborative efforts with cancer organizations from various European countries, including but not limited to Italy, Croatia, Estonia, and Slovenia. Qualitative online focus group discussions for each stakeholder will be conducted and transcribed. Subsequently, thematic analysis will be used to identify reasons and aspects that may contribute to the existing disparities in cancer outcomes at various levels of engagement and from different stakeholders' perspectives. Results from focus groups will inform a subsequent Delphi study and a SWOT analysis methodology.

Discussion: Although advances in medical research, cancer screening and treatment options are constantly progressing, disparities in access to and awareness of healthcare in cancer patients are even more noticeable. Thus, mapping the capacity and capability of cancer centres in the European Union, creating decision support tools that will assist the four stakeholders' information needs and improving the quality of European cancer centres will be the main objectives of the BEACON project. The current protocol will outline the methodological and practical procedures to conduct online focus group discussions with different stakeholders.

Citing Articles

Cancer burden in Europe: a systematic analysis of the GLOBOCAN database (2022).

Elmadani M, Mokaya P, Omer A, Kiptulon E, Klara S, Orsolya M BMC Cancer. 2025; 25(1):447.

PMID: 40075331 PMC: 11905646. DOI: 10.1186/s12885-025-13862-1.

Patients' perspectives on cancer care disparities in Central and Eastern European countries: experiencing taboos, misinformation and barriers in the healthcare system.

Coppini V, Ferraris G, Ferrari M, Daho M, Kirac I, Renko I Front Oncol. 2024; 14:1420178.

PMID: 39184044 PMC: 11341380. DOI: 10.3389/fonc.2024.1420178.

Understanding Reasons for Cancer Disparities in Italy: A Qualitative Study of Barriers and Needs of Cancer Patients and Healthcare Providers.

Ferraris G, Coppini V, Ferrari M, Monzani D, Grasso R, Pravettoni G Cancer Control. 2024; 31:10732748241258589.

PMID: 38897992 PMC: 11189013. DOI: 10.1177/10732748241258589.

References

Elfstrom K, Arnheim-Dahlstrom L, von Karsa L, Dillner J . Cervical cancer screening in Europe: Quality assurance and organisation of programmes. Eur J Cancer. 2015; 51(8):950-68. DOI: 10.1016/j.ejca.2015.03.008. View

Negri E, La Vecchia C . Epidemiology and prevention of bladder cancer. Eur J Cancer Prev. 2001; 10(1):7-14. DOI: 10.1097/00008469-200102000-00002. View

Quinn M, Babb P, Jones J, Allen E . Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999; 318(7188):904-8. PMC: 27810. DOI: 10.1136/bmj.318.7188.904. View

Gonzales F, Sangaramoorthy M, Dwyer L, Shariff-Marco S, Allen A, Kurian A . Patient-clinician interactions and disparities in breast cancer care: the equality in breast cancer care study. J Cancer Surviv. 2019; 13(6):968-980. PMC: 10187984. DOI: 10.1007/s11764-019-00820-7. View

Stewart J, Bertoni A, Staten J, Levine E, Gross C . Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007; 14(12):3328-34. DOI: 10.1245/s10434-007-9500-y. View

Mills E, Seely D, Rachlis B, Griffith L, Wu P, Wilson K . Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006; 7(2):141-8. DOI: 10.1016/S1470-2045(06)70576-9. View

Lange L, Fink J, Bleich C, Graefen M, Schulz H . Effectiveness, acceptance and satisfaction of guided chat groups in psychosocial aftercare for outpatients with prostate cancer after prostatectomy. Internet Interv. 2018; 9:57-64. PMC: 6096258. DOI: 10.1016/j.invent.2017.06.001. View

Lawler M, Duffy S, La Vecchia C, Le Chevalier T, Selby P, Sullivan R . America's cancer care crisis--is Europe any better?. Lancet. 2013; 382(9905):1628. DOI: 10.1016/S0140-6736(13)62362-4. View

Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N . The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021; 157:308-347. PMC: 8568058. DOI: 10.1016/j.ejca.2021.07.039. View

10.

Coleman M, Allemani C . Cancer: the elephant in the room. Lancet. 2015; 385(9973):1047-8. DOI: 10.1016/S0140-6736(15)60571-2. View

11.

Hennink M, Kaiser B, Weber M . What Influences Saturation? Estimating Sample Sizes in Focus Group Research. Qual Health Res. 2019; 29(10):1483-1496. PMC: 6635912. DOI: 10.1177/1049732318821692. View

12.

. Stop cancer now!. Lancet. 2013; 381(9865):426-7. DOI: 10.1016/S0140-6736(13)60060-4. View

13.

Blay J, Casali P, Bouvier C, Dehais C, Galloway I, Gietema J . European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN. ESMO Open. 2021; 6(4):100174. PMC: 8219752. DOI: 10.1016/j.esmoop.2021.100174. View

14.

Jenkins V, Fallowfield L, Saul J . Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer. 2001; 84(1):48-51. PMC: 2363610. DOI: 10.1054/bjoc.2000.1573. View

15.

Gigerenzer G . Towards a paradigm shift in cancer screening: informed citizens instead of greater participation. BMJ. 2015; 350:h2175. DOI: 10.1136/bmj.h2175. View

16.

Denicoff A, McCaskill-Stevens W, Grubbs S, Bruinooge S, Comis R, Devine P . The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract. 2013; 9(6):267-76. PMC: 3825288. DOI: 10.1200/JOP.2013.001119. View

17.

Hendren S, Griggs J, Epstein R, Humiston S, Rousseau S, Jean-Pierre P . Study protocol: a randomized controlled trial of patient navigation-activation to reduce cancer health disparities. BMC Cancer. 2010; 10:551. PMC: 2964637. DOI: 10.1186/1471-2407-10-551. View

18.

Gatti R, Di Paola A, Monaco A, Velichevskaya A, Amoroso N, Bellotti R . A ten-year (2009-2018) database of cancer mortality rates in Italy. Sci Data. 2022; 9(1):638. PMC: 9586951. DOI: 10.1038/s41597-022-01729-0. View

19.

Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F . Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol. 2016; 71(1):96-108. DOI: 10.1016/j.eururo.2016.06.010. View

20.

Warren E, Footman K, Tinelli M, Mckee M, Knai C . Do cancer-specific websites meet patient's information needs?. Patient Educ Couns. 2014; 95(1):126-36. DOI: 10.1016/j.pec.2013.12.013. View